Important study from the SAL study group for patient selection allo vs. cons.

pubmed.ncbi.nlm.nih.gov/36757706/

What an incredible sound of 8500+ school #youngvoices singing joyously The O2 tonight.. great fun!

Great to see Maribavir now made available in UK for refractory/resistant CMV infections in post BMT #immunocompromised patients. Much needed intervention..nice.org.uk/guidance/ta860… NHS England British Society of Blood & Marrow Transplantation KHP Haematology NICE

Mycology conference is returning in 2023! Here is what you need to know 👇

📅 24th and 25th March
📍QEII Conference Centre, London
🌐 Virtual event platform
📝 Abstract submissions are open
🎨 FungArt is back!

Register now at mycologyconference.co.uk

#Mycology2023

Sharing our comprehensive review on Radiometal chelators Frontiers and how it can potentially change #infectiondiagnostics in #Immunocompromised patients.Thanks to our collaborative efforts with world class expertise King's College London and KHP Haematology frontiersin.org/articles/10.33…

Wishing all my Twitter friends and colleagues a safer, healthier and happier New Year 2023.. #goodbye2022 KHP Haematology myeloidteamkings

A banterful fun (with some education) evening with our trainees/fellows on our King’s annual Haem SpR networking dinner evening! And some yummy #indianstreetfood . Jennifer Vidler Kali Majumder KHP Haematology properly kicking in the festive cheer..🍷

Delighted to work with some world leading experts over last 2 years at 9th ECIL developing recommendations on #COVID19 and management of #Toxoplasmosis in Haem-Onc patients.. learnt loads & look 4wrd to present our work in Nice,Fr this wk The EBMT EORTC ecil-leukaemia.com/en/

Congratulations! Well deserved

Last days to register for the The EBMT ADWP Meeting 2022: ebmt.org/events/autoimm….
It will cover all aspects of HSCT, cellular therapies, CAR-T cells, in autoimmune diseases, current and future indications, immunological mechanisms, novel targets.The EBMT_Trainee The EBMT_Nurses

A reminder to look out for the off target effects of JAKi in treating #GVHD , that may lead to some rare and difficult to treat pathologies in our #HSCT patients. #dermpath
just published.. onlinelibrary.wiley.com/share/author/F…

We will miss you Francesco!

RECOVERY publication in The Lancet

Baricitinib reduces risk of death in patients hospitalised for COVID-19.

514/4148 (12%) pts allocated to baricitinib vs
546/4008 (14%) pts allocated to usual care
died within 28 days
(age-adjusted rate ratio 0·87; 95% CI 0·77–0·99; p=0·028).

👉🏻Diagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel AML Hub ASTCT ASH The EBMT ashpublications.org/blood/article/…

Looking forward to chair this exciting educational/networking F2F event on 27th June ⁦⁦RC of Pathologists⁩ London⁩ #GVHD #Covid19 #HSCT with ⁦@DaniEinthoven⁩ ⁦Hugues de Lavallade⁩ and key note by Prof Zeiser. Join us if you are in London..(HCPs) linkedin.com/posts/therakos…

Read ‘Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission’ in Blood Journal spkl.io/60114TJCX

#openaccess ASH